Back
Virax Biolabs Group Ltd. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
VRAX
Virax Biolabs Group Ltd.
Last Price:
$0.39
Seasonality Move:
-34.96%
7 Day Trial
ALL ACCESS PASS
$
7
Virax Biolabs Group Ltd. Stock Forecast
-
Is Virax Biolabs Group Ltd. Stock Undervalued?The current Virax Biolabs Group Ltd. [VRAX] share price is $0.39. The Score for VRAX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
VRAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Virax Biolabs Group Ltd. Stock Go Up Next Year?
Data Unavailable
Virax Biolabs Group Ltd. Stock Rating
Data Unavailable
Virax Biolabs Group Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
viraxbiolabs.com
52-Week Data
52-Week High:
3.20
52-Week Low:
0.35
Prediction Charts
Market Cap:
2.6M
Price in USD:
0.39
Volume:
144.2K
Beta:
1.58
Technical Analysis
SMA50:
0.51
SMA100:
0.59
SMA200:
0.81
52-Wk Change:
-79.38%
Stock Predictions
-
Is Virax Biolabs Group Ltd. stock public?Yes, Virax Biolabs Group Ltd. is a publicly traded company.
-
What is the Virax Biolabs Group Ltd. stock quote today?The Virax Biolabs Group Ltd. stock price is 0.39 USD today.
-
How to buy Virax Biolabs Group Ltd. stock online?You can buy Virax Biolabs Group Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 0.42 | 0.39 | 0.42 | 0.39 |
| Dec-3 | 0.84 | 0.69 | 0.87 | 0.51 |
| Dec-4 | 0.64 | 0.64 | 0.65 | 0.56 |
| Dec-5 | 0.60 | 0.63 | 0.64 | 0.60 |
| Dec-8 | 0.62 | 0.53 | 0.62 | 0.52 |
| Dec-9 | 0.52 | 0.47 | 0.52 | 0.45 |
| Dec-10 | 0.50 | 0.49 | 0.50 | 0.46 |
| Dec-11 | 0.48 | 0.44 | 0.48 | 0.43 |
| Dec-12 | 0.44 | 0.45 | 0.47 | 0.44 |
| Dec-15 | 0.45 | 0.41 | 0.50 | 0.41 |
| Dec-16 | 0.40 | 0.40 | 0.41 | 0.39 |
| Dec-17 | 0.40 | 0.40 | 0.43 | 0.40 |
| Dec-18 | 0.40 | 0.39 | 0.42 | 0.39 |
| Dec-19 | 0.38 | 0.39 | 0.41 | 0.38 |
Virax Biolabs Group Ltd. Earnings
Data Unavailable
Virax Biolabs Group Ltd. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.47 per share.
* Virax Biolabs Group Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.